Devika Proteins monitoring committee to hold second meeting

Dharti Proteins Limited (formerly Devika Proteins Limited) has announced its second monitoring committee meeting will be held on Saturday, December 27, 2025, via electronic mode. This meeting follows the National Company Law Tribunal (NCLT) approval of a resolution plan submitted by Shri Jatin Ramanbhai Patel, the "Resolution Applicant," on November 18, 2025. The NCLT approval order was also uploaded to the NCLT website on the same date.

The announcement was made by IP Amrish Gandhi, the resolution professional for Dharti Proteins Limited, whose credentials include IBBI/IPA-002/IP-N00670/2018-2019/12036 and AFA Number AA2/12036/02/311225/203618, valid until December 31, 2025.

The company is headquartered in Ahmedabad, Gujarat, India. This intimation was directed to the Department of Corporate Services at the Bombay Stock Exchange Limited, where the company is listed under Company Code: 531171 and ISIN: INE248C01013.